Cite
HARVARD Citation
Bianchini, M. et al. (2022). Cost-Effectiveness Analysis of New Beta-Lactam Beta-Lactamase Inhibitor Antibiotics Versus Colistin for the Treatment of Carbapenem-Resistant Infections. Hospital pharmacy. pp. 93-100. [Online].